(Q81353149)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17895878%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

title

Limitations and use of PSA velocity in the diagnosis and characterization of prostate cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17895878%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

Andrew D Smith

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17895878%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

John L Phillips

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17895878%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

publication date

25 September 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17895878%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

published in

Nature Reviews Urology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17895878%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17895878%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17895878%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

576-577

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17895878%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/ncpuro0936

8 January 2020

exact match

0 references

cites work

Recurrence patterns after radical retropubic prostatectomy: clinical usefulness of prostate specific antigen doubling times and log slope prostate specific antigen

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0936

7 January 2021

Pretreatment PSA velocity and risk of death from prostate cancer following external beam radiation therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0936

7 January 2021

Preoperative prostate specific antigen doubling time and velocity are strong and independent predictors of outcomes following radical prostatectomy

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0936

7 January 2021

Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0936

7 January 2021

Preoperative PSA velocity is an independent prognostic factor for relapse after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0936

7 January 2021

Preoperative PSA velocity and doubling time do not predict adverse pathologic features or biochemical recurrence after radical prostatectomy.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0936

7 January 2021

Prostate-specific antigen recurrence and mortality after conventional dose radiation therapy in select men with low-risk prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0936

7 January 2021

Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0936

7 January 2021

Baseline prostate-specific antigen compared with median prostate-specific antigen for age group as predictor of prostate cancer risk in men younger than 60 years old.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0936

7 January 2021

Prediagnostic prostate-specific antigen velocity and probability of detecting high-grade prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0936

7 January 2021